Description
FLT3 genotyping, within the field of pharmacogenomics, involves analyzing the FLT3 gene to identify specific mutations that can influence a patient’s response to certain drugs, particularly those used in treating acute myeloid leukemia (AML). This testing helps determine the most effective and safest treatment approach for individuals based on their genetic makeup.
Reviews
There are no reviews yet.